how to choose among the phosphate binders for patients with chronic kidney disease

May 2011

There's confusion about how to choose among the phosphate binders for patients with chronic kidney disease.

These have similar efficacy for lowering phosphate levels...but they vary in adverse effects, cost, and number of pills needed.

Aluminum hydroxide isn't used chronically anymore. Aluminum accumulates and leads to bone disease, dementia, and death.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote